Form 4 for QDEL QuidelOrtho Corp
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020502 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | QDEL | Bujarski Robert Joseph | See Remarks | A - Grant | — | +29.2K | 29.2K | New | — |
| DM | 2022-06-01 | 2022-05-27 | QDEL | Bujarski Robert Joseph | See Remarks | A - Grant | $0.00 | +130.9K | 9,212 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 29,164 | — | 29,164 | D | — | — | (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. |
| 2 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 7,246 | $0.00 | 7,246 | D | $59.12 · — to 2029-02-04 | 7,246 Common Stock | (F4) 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023. |
| 3 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 6,641 | $0.00 | 6,641 | D | $77.16 · — to 2030-02-03 | 6,641 Common Stock | (F5) 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| 4 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 2,935 | $0.00 | 2,935 | D | $159.39 · — to 2030-09-14 | 2,935 Common Stock | (F6) 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024. |
| 5 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 3,514 | $0.00 | 3,514 | D | $254.00 · — to 2031-02-01 | 3,514 Common Stock | (F7) 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. |
| 6 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 12,876 | $0.00 | 12,876 | D | $103.36 · — to 2032-01-31 | 12,876 Common Stock | (F8) 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026. |
| 7 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 3,623 | $0.00 | 3,623 | D | — · — to — | 3,623 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F11) 3,623 shares will vest on February 4, 2023. |
| 8 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 2,749 | $0.00 | 2,749 | D | — · — to — | 2,749 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 9 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 824 | $0.00 | 824 | D | — · — to — | 824 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 10 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,033 | $0.00 | 1,033 | D | — · — to — | 1,033 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F13) 1,033 shares will vest on November 18, 2022. |
| 11 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 3,320 | $0.00 | 3,320 | D | — · — to — | 3,320 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F14) 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| 12 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,052 | $0.00 | 1,052 | D | — · — to — | 1,052 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 13 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 315 | $0.00 | 315 | D | — · — to — | 315 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 14 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 941 | $0.00 | 941 | D | — · — to — | 941 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F15) 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024. |
| 15 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,351 | $0.00 | 1,351 | D | — · — to — | 1,351 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 16 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 405 | $0.00 | 405 | D | — · — to — | 405 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 17 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 2,637 | $0.00 | 2,637 | D | — · — to — | 2,637 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F16) 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| 18 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,559 | $0.00 | 1,559 | D | — · — to — | 1,559 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F17) 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. |
| 19 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 12,878 | $0.00 | 12,878 | D | — · — to — | 12,878 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F18) 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026. |
| 20 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 13,545 | $0.00 | 13,545 | D | — · — to — | 13,545 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F19) 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. |
| 21 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,190 | $0.00 | 1,190 | D | — · — to — | 1,190 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 22 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 357 | $0.00 | 357 | D | — · — to — | 357 Common Stock | (F9) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. (F20) 357 shares will vest on January 31, 2023. |
| 23 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 8,798 | $0.00 | 8,798 | D | $23.41 · — to 2025-02-05 | 8,798 Common Stock | (F3) Vested in full. |
| 24 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 17,596 | $0.00 | 17,596 | D | $15.40 · — to 2026-02-10 | 17,596 Common Stock | (F3) Vested in full. |
| 25 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 14,343 | $0.00 | 14,343 | D | $21.08 · — to 2027-02-15 | 14,343 Common Stock | (F3) Vested in full. |
| 26 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 9,212 | $0.00 | 9,212 | D | $46.41 · — to 2028-01-16 | 9,212 Common Stock | (F3) Vested in full. |